The level of free circulating mitochondrial DNA in blood as predictor of death in case of acute coronary syndrome

The efficacy of treating acute myocardial ischemic damages depends, to a large extent, on the development of technologies for predicting their course and outcome. The aim of this paper was to explore whether it would be possible to consider the content of free circulating mitochondrial DNA as a dang...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medical research 2017-01, Vol.22 (1), p.1-1, Article 1
Main Authors: Sudakov, Nikolay P, Apartsin, Konstantin A, Lepekhova, Svetlana A, Nikiforov, Sergey B, Katyshev, Alexander I, Lifshits, Galina I, Vybivantseva, Anna V, Konstantinov, Yuri M
Format: Article
Language:English
Subjects:
Acute coronary syndrome
Acute Coronary Syndrome - blood
Acute Coronary Syndrome - mortality
Aged
Aged, 80 and over
Biomarkers - blood
DNA, Mitochondrial - blood
Female
Genetic aspects
Health aspects
Humans
Innovations
Logistic Models
Male
Middle Aged
Mitochondrial DNA
Molecular diagnostic techniques
Patient outcomes
Prospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The efficacy of treating acute myocardial ischemic damages depends, to a large extent, on the development of technologies for predicting their course and outcome. The aim of this paper was to explore whether it would be possible to consider the content of free circulating mitochondrial DNA as a danger-associated molecular pattern for assessing the probability of death from myocardial infarction. We have analyzed the clinical outcomes based on discharge summaries and autopsy reports obtained in the course of the PROTOCOL observational trial. This study was approved by the Irkutsk Scientific Center of Surgery and Traumatology ethics committee (protocol No. 3, 10.08.2015). To examine whether the assessment of the level of free circulating mtDNA in acute coronary syndrome can help predicting clinical outcomes, all patients were divided into two groups: group 1, involving those who survived during 30 days after hospitalization, and group 2, involving those who died during this time. A quantitative analysis of the free circulating mtDNA was conducted using the PCR method in situ. The analysis showed that in patients who survived the level of freely circulating mtDNA (36.0 copies/ml) was 164 times lower than in those who died (5900 copies/ml, p = 0.049). It should be mentioned that according to the logistic regression analysis, the probability of death of patients with the increased level of blood plasma mtDNA (more than 4000 copies/ml) is 50%. Thus, the PROTOCOL observational trial proved that the increase in the content of free circulating mtDNA in blood is a predictor of lethal outcome in patients with acute coronary syndrome. Trial registration The observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) do not require registration.
ISSN:2047-783X
0949-2321
2047-783X
DOI:10.1186/s40001-016-0241-x